![David Liu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Liu
Corporate Officer/Principal bij
Harvard University
Vermogen: 59 M $ op 31-07-2026
Profiel
David R.
Liu is the founder of Ensemble Therapeutics Corp., founded in 2004, Permeon Biologics, Inc., founded in 2008, Editas Medicine, Inc., founded in 2013, and Exo Therapeutics, Inc., founded in 2018.
Dr. Liu is also the founder of nChroma Bio, Inc.,Prime Medicine, Inc.,Pairwise Plants Services, Inc...
Dr. Liu is currently a Professor at Harvard University.
Dr. Liu is currently an Associate Member at Massachusetts Institute of Technology.
Dr. Liu completed undergraduate education at Harvard University.
Dr. Liu earned a doctorate from the University of California, Berkeley.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
PRIME MEDICINE, INC. 11,73% | 31-03-2026 | 20.240.945 ( 11,73% ) | 59 M $ | 31-07-2026 |
Actieve functies van David Liu
| Bedrijven | Functie | Begin |
|---|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 06-09-2011 |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Corporate Officer/Principal | 06-09-2011 |
Eerdere bekende functies van David Liu
| Bedrijven | Functie | Einde |
|---|---|---|
| PRIME MEDICINE, INC. | Oprichter | - |
Exo Therapeutics, Inc.
 Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes | Oprichter | - |
Pairwise Plants Services
 Pairwise Plants Services Food: Major DiversifiedConsumer Non-Durables Engages in cultivation of crops | Oprichter | - |
| EDITAS MEDICINE, INC. | Oprichter | - |
Opleiding van David Liu
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
100
+
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Ensemble Therapeutics Corp.
 Ensemble Therapeutics Corp. Chemicals: Major DiversifiedProcess Industries Develops novel classes of therapeutics and bioassays for research and diagnostics | Process Industries |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Permeon Biologics, Inc.
 Permeon Biologics, Inc. BiotechnologyHealth Technology Develops intracellular biotherapeutics platform to enhance drug delivery | Health Technology |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
Pairwise Plants Services
Pairwise Plants Services Food: Major DiversifiedConsumer Non-Durables Engages in cultivation of crops | Consumer Non-Durables |
Exo Therapeutics, Inc.
Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes | Health Technology |
Prime Medicine, Inc.
 Prime Medicine, Inc. BiotechnologyHealth Technology Develops CRISPR gene editing technology | Health Technology |
